Wesley C. Van Voorhis
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Microbiology BiologyGoogle:
"Wesley Van Voorhis"Children
Sign in to add trainee| Cecilia A. Morgan | grad student | 2002 | University of Washington |
| Eileen S. Sun | grad student | 2004 | University of Washington |
| Richard T Eastman | grad student | 2002-2006 | University of Washington (ID Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jiménez-Meléndez A, Ojo KK, Wallace AM, et al. (2017) In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites. International Journal For Parasitology |
| Ojo KK, Dangoudoubiyam S, Verma SK, et al. (2016) Selective inhibition of Sarcocystis neurona calcium-cependent protein kinase 1 for equine protozoal myeloencephalitis therapy. International Journal For Parasitology |
| Vidadala RS, Rivas KL, Ojo KK, et al. (2016) Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis. Journal of Medicinal Chemistry. 59: 6531-46 |
| Winzer P, Müller J, Aguado-Martínez A, et al. (2015) In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum. Antimicrobial Agents and Chemotherapy. 59: 6361-74 |
| Hines SA, Ramsay JD, Kappmeyer LS, et al. (2015) Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor. Parasites & Vectors. 8: 33 |
| Ojo KK, Eastman RT, Vidadala R, et al. (2014) A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation. The Journal of Infectious Diseases. 209: 275-84 |
| Johnson SM, Murphy RC, Geiger JA, et al. (2012) Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity. Journal of Medicinal Chemistry. 55: 2416-26 |
| Shibata S, Gillespie JR, Kelley AM, et al. (2011) Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice. Antimicrobial Agents and Chemotherapy. 55: 1982-9 |
| Ojo KK, Gillespie JR, Riechers AJ, et al. (2008) Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. Antimicrobial Agents and Chemotherapy. 52: 3710-7 |
| Arakaki TL, Buckner FS, Gillespie JR, et al. (2008) Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Molecular Microbiology. 68: 37-50 |